Antibody design using anti-lipid antibody crystal structures

Details for Australian Patent Application No. 2009322185 (hide)

Owner Lpath, Inc.

Inventors Sabbadini, Roger A.; Wojciak, Jonathan Michael; Huxford, Tom

Agent Spruson & Ferguson

Pub. Number AU-A-2009322185

PCT Pub. Number WO2010/065921

Priority 61/120,318 05.12.08 US; 61/155,895 26.02.09 US; 61/231,258 04.08.09 US

Filing date 4 December 2009

Wipo publication date 10 June 2010

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

21 July 2011 PCT application entered the National Phase

  PCT publication WO2010/065921 Priority application(s): WO2010/065921

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009322187-Phosphatidylinositol-3-kinase p110 delta-targeted drugs in the treatment of CNS disorders

2009322184-Compositions and methods for the treatment and prevention of lens fibrotic diseases